全球疼痛管理市場（2023-2030）：按應用（神經病變疼痛、癌症疼痛）和配銷通路（線上藥房、零售藥房）分類的規模、佔有率、成長分析和預測

Global Pain Management Market Size, Share, Growth Analysis, By Application (Neuropathic pain, cancer pain), By Distribution Channel(Online pharmacy, retail pharmacy) - Industry Forecast 2023-2030

出版日期: 2023年10月16日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

根據預測，全球疼痛管理市場規模將從2021年的721億美元成長到2030年的1,053.2億美元，而2022年為752億美元，預測期內年複合成長率為4.3%。

由於關節炎、癌痛、神經性疼痛和神經病變疾病等慢性疼痛疾病的盛行率不斷上升，全球疼痛管理市場正在顯著擴大。慢性疼痛患者的迅速增加推動了對有效止痛解決方案的需求。新型藥物、醫療設備和微創手術等疼痛管理技術的進步，以及神經調節和標靶藥物傳遞系統等先進技術的整合，正在擴大有效治療選擇的範圍。

然而，挑戰也存在，包括對鴉片類藥物濫用和成癮的擔憂，促使加強法規並轉向非鴉片替代來治療疼痛。因此，醫療保健提供者和製藥公司面臨著平衡緩解疼痛的需求與潛在風險的挑戰。

本報告調查了全球疼痛管理市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按各個細分市場和地區進行的細分。競爭形勢、主要企業概況等

執行摘要
調查方法
母市場分析
- 市場概況
- 市場規模
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
關鍵市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- 啟動分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 重點投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
  - 市場動態
    - 促進因素
    - 機會
    - 抑制因素
    - 任務
- 法規狀況
- 波特的分析
- Skyquest 對未來顛覆的獨家見解
全球疼痛管理市場：依應用分類
- 市場概況
- 神經性疼痛
- 癌症痛
- 臉部疼痛/偏頭痛
- 肌肉骨骼疼痛
- 其他
全球疼痛管理市場：按配銷通路
- 市場概況
- 網路藥房
- 零售藥房
- 醫院藥房
全球疼痛管理市場：按地區
- 市場概況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
競爭形勢
- 前5名企業對比
- 主要企業市場地位
- 主要企業的招募策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率
主要企業簡介
- Johnson & Johnson
- Pfizer Inc.
- Novartis International AG
- Eli Lilly and Company
- GlaxoSmithKline PLC
- AbbVie Inc.
- AstraZeneca PLC
- Bayer AG
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- Sanofi SA
- Bristol Myers Squibb Company
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- St. Jude Medical, Inc.
- Stryker Corporation
- Cardinal Health, Inc.
- Halyard Health (O&M Halyard)
- Mallinckrodt Pharmaceuticals

簡介目錄

Product Code: SQMIG35I2178

Global Pain Management Market size was valued at USD 72.1 Billion in 2021 and is poised to grow from USD 75.20 Billion in 2022 to USD 105.32 Billion by 2030, at a CAGR of 4.3% during the forecast period (2023-2030).

The global pain management market has experienced substantial expansion due to the rising prevalence of chronic pain conditions, including arthritis, cancer pain, neuropathic pain, and musculoskeletal disorders. This surge in chronic pain cases has driven demand for effective pain relief solutions. Advancements in pain management technologies, such as novel pharmaceuticals, medical devices, and minimally invasive procedures, along with the integration of advanced technologies like neuromodulation and targeted drug delivery systems, have broadened the range of effective treatment options. However, challenges exist, including concerns about opioid abuse and addiction, which have prompted stricter regulations and a shift toward non-opioid alternatives for pain management, thereby presenting healthcare providers and pharmaceutical companies with the task of balancing pain relief needs with potential risks.

Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global pain management market is segmented on the basis of application, distribution channel, and region. By application, the market is segmented into neuropathic pain, cancer pain, facial pain and migraine, musculoskeletal pain, and other applications. By distribution channel, the market is segmented into online pharmacy, retail pharmacy, and hospital pharmacy. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Awareness and Focus on Pain Management

A heightened understanding of pain's profound influence on people's well-being is prompting healthcare providers, patients, and policymakers to prioritize pain management, resulting in intensified research, education, and enhanced access to efficient pain relief. This emphasis on patient-centered care and better pain management outcomes is propelling the market forward.

Rising Geriatric Population

The pain management market is being notably influenced by the aging population, given that older adults are at a higher risk of experiencing chronic pain issues like osteoarthritis and neuropathic pain. As the world experiences a growing trend of aging demographics, the need for pain management solutions is on the rise, as elderly individuals actively seek efficient ways to alleviate pain and sustain their overall well-being and autonomy.

Restraints:

High Cost of Pain Management Treatments

The growth of the market for pain management treatments can be impeded by the high costs associated with advanced procedures and devices, which may hinder access for specific patient groups, especially in low-income regions or countries with limited healthcare resources. The expenses related to medications, surgical interventions, and specialized therapies pose a significant barrier to broader market expansion.

Regulatory and Reimbursement Challenges

The pain management industry is influenced by regulatory stipulations and reimbursement obstacles that can impede its expansion. Regulatory factors, such as constraints on opioid prescription and medical device regulations, play a pivotal role in shaping the accessibility of pain management solutions. Additionally, reimbursement policies and constraints can impact the adoption and utilization of specific pain management treatments.

Market Trends:

The current trend in pain management involves a growing focus on multimodal, personalized approaches that encompass a range of therapies and interventions to address pain comprehensively. This includes a combination of pharmaceutical treatments, non-pharmacological therapies, physical therapy, psychological interventions, and lifestyle modifications, all tailored to the specific needs of each patient, considering factors like the pain's underlying cause, comorbidities, and patient preferences. Additionally, minimally invasive procedures for pain relief, such as nerve blocks, radiofrequency ablation, and spinal cord stimulation, are becoming increasingly popular due to their targeted pain relief, reduced invasiveness, shorter recovery periods, and potential for fewer side effects when compared to traditional surgical methods, driven by advancements in medical technology and healthcare professionals' growing expertise.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Pain Management Market by Application
- Market Overview
- Neuropathic pain
- cancer pain
- facial pain and migraine
- musculoskeletal pain
- and other applications
Global Pain Management Market by Distribution Channel
- Market Overview
- Online pharmacy
- retail pharmacy
- and hospital pharmacy
Global Pain Management Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Pfizer Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Novartis International AG - Switzerland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Eli Lilly and Company - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- GlaxoSmithKline PLC - United Kingdom
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AbbVie Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- AstraZeneca PLC - United Kingdom
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bayer AG - Germany
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Merck & Co., Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Teva Pharmaceutical Industries Ltd. - Israel
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. - France
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Bristol Myers Squibb Company - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic PLC - Ireland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abbott Laboratories - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boston Scientific Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- St. Jude Medical, Inc. (Abbott) - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stryker Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cardinal Health, Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Halyard Health (O&M Halyard) - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Mallinckrodt Pharmaceuticals - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments